相关实验视频
Updated: Jun 7, 2025
11:53
Cecal Ligation Puncture Procedure
Published on: May 7, 2011
54.7K
在败血症和败血性休克中重新评估维生素C:在严重病例中潜在的益处?
Abdulrahman Alissa1, Mohammed A Alrashed2,3,4, Abdulrahman I Alshaya2,3,4
1Pharmaceutical Care Services, King Abdullah Bin Abdulaziz University Hospital, Riyadh, Saudi Arabia.
Frontiers in medicine
|November 14, 2024
概括
维生素C在败血症,特别是肺炎引起的病例中显示出潜力,通过支持内皮功能. 然而,临床试验尚未证实它对败血症和败血性休克患者的广泛益处.
科学领域:
- 关键护理医学 关键护理医学
- 营养生物化学 营养生物化学
- 传染性疾病 传染性疾病
背景情况:
- 维生素C (甲酸) 正在作为治疗败血症和败血性休克的联合干预措施进行研究.
- 研究表明,维生素C可以保护内皮功能,并改善败血症的微循环.
- 肺炎经常引发败血症和败血性休克,可能导致急性呼吸困扰综合征 (ARDS).
研究的目的:
- 审查和比较对维生素C治疗败血症和败血性休克的随机临床试验.
- 探索跨研究的患者群体,方法和结果的变化.
- 专门研究维生素C在肺炎引起的败血症和ARDS中的作用.
主要方法:
- 现有随机临床试验的比较综述.
- 分析患者的人口统计和临床特征.
- 评估研究方法和报告结果.
主要成果:
- 虽然病理生理学研究支持维生素C的作用,但大多数临床试验并没有在败血症和败血性休克中显示出显著的益处.
- 初步的体外试验数据表明,维生素C可能有助于减轻ARDS风险.
- 试验设计和患者人群的差异可能解释了各种结果.
结论:
- 尽管有理论上的好处,但维生素C在败血症和败血性休克的临床疗效仍然没有得到证实.
- 需要进一步的研究来澄清维生素C的作用,特别是在肺炎引起的败血症和ARDS.
- 确定特定的患者亚组或优化干预方案可能是证明维生素C有效性的关键.
相关概念视频
01:29Acute Respiratory Failure-V
123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123
01:30Vitamins
565
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
565
01:28Pneumonia IV: Management
299
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
299
01:30Pneumonia III: Complications and Assessment
170
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
170
01:29Endocarditis IV: Nursing Management
2
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
2